Celltrion
068270.KS
#749
Rank
โ‚น2.321 T
Marketcap
โ‚น11,292
Share price
1.25%
Change (1 day)
8.42%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น253.23. In 2022 the company made an earnings per share (EPS) of โ‚น246.53 a decrease over its 2021 EPS that were of โ‚น292.93.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-0.51%
2022โ‚น246.53-15.84%
2021โ‚น292.9312.77%
2020โ‚น259.7570.79%
2019โ‚น152.0915.63%
2018โ‚น131.53-33.13%
2017โ‚น196.71141.17%
2016โ‚น81.578.28%
2015โ‚น75.3311.28%
2014โ‚น67.6916.37%
2013โ‚น58.17-67.42%
2012โ‚น178.5784.22%
2011โ‚น96.9362.13%
2010โ‚น59.7980.61%
2009โ‚น33.10-559.63%
2008-โ‚น7.20-123.16%
2007โ‚น31.10